Holen Sie sich die Stockscreener-App
2.42
0.82%
-0.02
Handel nachbörslich:
2.49
0.07
+2.89%
Schlusskurs vom Vortag:
$2.44
Offen:
$2.45
24-Stunden-Volumen:
88,500
Relative Volume:
0.06
Marktkapitalisierung:
$7.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.85M
KGV:
-0.3619
EPS:
-6.6877
Netto-Cashflow:
$-8.00M
1W Leistung:
+6.61%
1M Leistung:
-24.38%
6M Leistung:
-75.10%
1J Leistung:
-86.75%
1-Tages-Spanne:
$2.4001
$2.5256
1-Wochen-Bereich:
$2.20
$2.53
52-Wochen-Spanne:
$2.06
$135.54
Alzamend Neuro Inc Stock (ALZN) Company Profile
Firmenname
Alzamend Neuro Inc
Sektor
Branche
Telefon
844-722-6333
Adresse
3500 LENOX RD. NE, ATLANTA
Vergleichen Sie ALZN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.42 | 7.66M | 0 | -5.85M | -8.00M | -6.6877 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-01 | Eingeleitet | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc Aktie (ALZN) Neueste Nachrichten
Can Alzamend Neuro Inc. hit a new high this monthPortfolio Update Summary & Proven Capital Preservation Methods - Newser
Signal strength of Alzamend Neuro Inc. stock in tech scanners2025 Price Targets & Breakout Confirmation Trade Signals - Newser
Alzamend Neuro Inc. stock momentum explainedTrade Analysis Summary & Real-Time Market Sentiment Alerts - Newser
Why Alzamend Neuro Inc. stock attracts strong analyst attentionWeekly Trend Summary & Fast Entry High Yield Stock Tips - Newser
Can technical indicators confirm Alzamend Neuro Inc.’s reversalShare Buyback & Precise Trade Entry Recommendations - Newser
Visualizing Alzamend Neuro Inc. stock with heatmapsJuly 2025 Action & Risk Controlled Swing Trade Alerts - Newser
Will Alzamend Neuro Inc. rebound enough to break evenEarly Buy Opportunity with Chart Triggers - Newser
Key resistance and support levels for Alzamend Neuro Inc. [Quarterly Trade Report]Free Weekly Market Pulse Updates - Newser
Leading vs lagging indicators on Alzamend Neuro Inc. performanceFree Watchlist for Smart Swing Trading - Newser
Tools to monitor Alzamend Neuro Inc. recovery probabilityHigh Probability Trade Plan with Indicators - Newser
Will Alzamend Neuro Inc. outperform the marketWeekly Stock Movement Prediction Watchlist - Newser
Regression analysis insights on Alzamend Neuro Inc. performanceDaily Stock Forecast Powered by AI Tools - Newser
Alzamend Neuro Inc. stock volume spike explainedFree Alpha Focused Technical Trade Signals - Newser
How Alzamend Neuro Inc. stock performs during market volatilityPattern Breakout Prediction for Short Term - Newser
What MACD and RSI say about Alzamend Neuro Inc.Stock Entry Point Planner with Volume Spike - Newser
Head-To-Head Review: Alzamend Neuro (NASDAQ:ALZN) & BioAtla (NASDAQ:BCAB) - Defense World
Alzamend Neuro (NASDAQ:ALZN) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Published on: 2025-08-09 00:00:57 - Newser
Key resistance and support levels for Alzamend Neuro Inc.Free Optimized Watchlist With Daily Adjustments - Newser
Alzamend Neuro Inc. Moves Into Overbought Range Analysts CautiousReal Profit Trade Plan Suggestions Shared Widely - beatles.ru
Published on: 2025-08-04 23:59:05 - metal.it
What is the dividend policy of Alzamend Neuro Inc. stockAchieve consistent profits with expert advice - Jammu Links News
What are Alzamend Neuro Inc. company’s key revenue driversUnlock exclusive trading tools and resources - Jammu Links News
What are the latest earnings results for Alzamend Neuro Inc.Unlock exclusive investment alerts - Jammu Links News
Is Alzamend Neuro Inc. a growth stock or a value stockLightning-fast capital gains - Jammu Links News
What are the technical indicators suggesting about Alzamend Neuro Inc.Free Investment Community - Jammu Links News
Finanzdaten der Alzamend Neuro Inc-Aktie (ALZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):